The Fas antigen is a member of the Tumor Necrosis Factor (TNF) Receptor family that transduces signals resulting in apoptotic cell death. In HIV infection, recent data suggest that both CD4+ and CD8+ T-cells are depleted through poorly understood mechanisms involving apoptosis. A role for Fas in this process has been hypothesized. The mechanisms by which Fas induces cell death remain enigmatic. Recently, however, two intracellular proteins have been identified that interact with the cytosolic domain of Fas, including MORT-1/FADD and RIP, a kinase. Both of these proteins bind to a conserved domain in Fas that is required for induction of apoptosis (the death domain) and trigger apoptosis when over-expressed in cells. Regulation of Fas-induced apoptosis in T-cells is complex, with activated T-cells fluctuating between Fas-sensitive and Fas-resistant states. Peripheral T-cells from HIV-infected persons contain abnormally high proportions of Fas-sensitive T-cells. During attempts to understand mechanisms of Fas-signaling, the PI identified a protein tyrosine phosphatase (PTPase), which he termed Fas-Associated Phosphatase-1 (FAP-1), that binds to a negative regulatory region in the cytosolic domain of Fas and that blocks Fas-induced apoptosis. The PI now proposes to explore the expression and function of FAP-1 in T-cells from normal and HIV-infected persons. Among the specific questions that will be addressed are: (1) Does the regulation of FAP-1 expression in peripheral T-cells from normal and HIV-infected individuals correlate with sensitivity and resistance to Fas-mediated apoptosis in vitro?; (2) What effect does FAP-1 have on apoptosis in induced by anti-CD3, anti-CD4, SEB, or gp120/anti-gp120 antibodies in HIV-Tat-sensitized T cells?; and (3) How does FAP-1 modulate the biochemical Fas-initiated signal transduction events that lead to apoptosis in T-cells? These latter studies will include investigation of the functional and physical interactions of FAP-1 with the other Fas-binding proteins, MORT-1/FADD and RIP. Taken together, the results of these studies will contribute to an improved understanding of the cytotoxic mechanism by which Fas regulates apoptosis of T-cells in normalcy and HIV infection.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA072994-02
Application #
2443320
Study Section
AIDS and Related Research Study Section 1 (ARRA)
Project Start
1996-07-21
Project End
1999-06-30
Budget Start
1997-07-01
Budget End
1998-06-30
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Sanford-Burnham Medical Research Institute
Department
Type
DUNS #
009214214
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Meinhold-Heerlein, I; Stenner-Liewen, F; Liewen, H et al. (2001) Expression and potential role of Fas-associated phosphatase-1 in ovarian cancer. Am J Pathol 158:1335-44
Leo, E; Deveraux, Q L; Buchholtz, C et al. (2001) TRAF1 is a substrate of caspases activated during tumor necrosis factor receptor-alpha-induced apoptosis. J Biol Chem 276:8087-93
Wang, Z; Morris, G F; Reed, J C et al. (1999) Activation of Bcl-2 promoter-directed gene expression by the human immunodeficiency virus type-1 Tat protein. Virology 257:502-10
Torii, S; Egan, D A; Evans, R A et al. (1999) Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs). EMBO J 18:6037-49
Stennicke, H R; Deveraux, Q L; Humke, E W et al. (1999) Caspase-9 can be activated without proteolytic processing. J Biol Chem 274:8359-62
Su, Z Z; Madireddi, M T; Lin, J J et al. (1998) The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice. Proc Natl Acad Sci U S A 95:14400-5
Miyashita, T; Nagao, K; Krajewski, S et al. (1998) Investigation of glucocorticoid-induced apoptotic pathway: processing of caspase-6 but not caspase-3. Cell Death Differ 5:1034-41
Zapata, J M; Takahashi, R; Salvesen, G S et al. (1998) Granzyme release and caspase activation in activated human T-lymphocytes. J Biol Chem 273:6916-20
Stennicke, H R; Jurgensmeier, J M; Shin, H et al. (1998) Pro-caspase-3 is a major physiologic target of caspase-8. J Biol Chem 273:27084-90
Takahashi, R; Deveraux, Q; Tamm, I et al. (1998) A single BIR domain of XIAP sufficient for inhibiting caspases. J Biol Chem 273:7787-90

Showing the most recent 10 out of 12 publications